Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01401348 · ClinicalTrials.gov registry record
Stanford Universities: The Stanford HIV Aging Cohort
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 154
- Enrollment target
NCT01401348: Completed study, sponsored by Stanford University.
NCT01401348 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01401348 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
Study Summary
A research study to evaluate the effect of aging and HIV on neurocognitive dysfunction (declining ability to process information), physical frailty and heart disease. HIV-infected participants whose virus is controlled on antiretroviral medications will be studied to determine the rates and risk factors of developing these conditions.
Primary Outcome
Controlled oral word association test-FAS, Paced auditory serial addition task, trail making a and b, REY auditory verbal learning test, grooved peg board, timed gait
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2010-12 |
| Est. Completion | 2015-12 |
What the finished NCT01401348 record still lists
NCT01401348 is an observational study that tracks outcomes without assigning an intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01401348 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01401348 about?
NCT01401348 is a clinical study titled "Stanford Universities: The Stanford HIV Aging Cohort". A research study to evaluate the effect of aging and HIV on neurocognitive dysfunction (declining ability to process information), physical frailty and heart disease. HIV-infected participants whose virus is controlled on antiretroviral medications will be studied to determine the rates and risk fac...
What is the current status of trial NCT01401348?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2010-12. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01401348?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia